Chapter 3 added and the mixture was stirred at room temperature for 3 hour. THF was evaporated and the product was precipitated as a white solid at pH= 7.5, filtered and dried under vacuum. Yield: 75%. 1 H-NMR (300MHz , DMSO-d 6 ): δ (ppm) 7.97 (bs, 1H, N-Hη arginine side chain), 7.64 (d, 2H, J(H,H)= 8 Hz, CH aromatic tosyl group), 7.29 (d, 2H, J(H,H) = 8 Hz, CH aromatic tosyl group), 7.18 (bs, 1H, N η -H arginine side chain), 6.99 (bs, 1H, NH-Boc), 3.29- 3.05 (m, 5H, C(2)Hα + Glyψ CH 2 CH 2 ), 2.79-2.69 (m, 2H, CH 2 arginine side chain), 2.34 (s, 3H, CH 3 tosyl group), 1.73-1.40 (m, 4H, CH 2 arginine side chain), 1.38 (s, 9H, CH 3 Boc group). 13 C-NMR ( 75 MHz, DMSO-d 6 ): δ (ppm) 170.8, 156.8, 155.5, 141.6, 140.8, 128.9, 125.4, 77.9, 61.0, 45.9, 37.1, 28.0, 27.2, 25.0, 20.7. ESI-MS (CH 3 OH, positive ions): calculated m/z: 472.6 (MH + ), 494.6 (MNa + ), 510.7 (MK + ), found: 472.4, 494.4, 510.4 N α -Boc-Glyψ-[D-Arg-(N α -Fmoc)-(N ω -Tosyl)]-OH. Bis(trimethylsilyl)acetamide (BTSA) (0.21ml, 0.86 mmol) and DIPEA ( 0.05ml, 0.29 mmol) were added to N α -Boc-Glyψ-[D-Arg- (N ω -Tosyl)]-OH (0.14g, 0.29 mmol) suspended in DCM (15 ml), with exclusion of humidity by a CaCl 2 drying tube. When the solution was nearly clear (10-15 min were usually required), FmocCl (0.1g, 0.58 mmol) was added and the mixture was stirred for 2 hours at room temperature. Methanol (1 ml ) was carefully added and the mixture was stirred for an additional 15 min, diluted with 15 ml of DCM, washed with 1M potassium hydrogen sulphate (3 times) and brine (3 times), dried over magnesium sulfate and evaporated to dryness. The residue was purified by flash chromatography (dichlomethane:methanol = 9:1) and the product was obtained as a white foam. Yield: 38%. 1 H NMR (300MHz, DMSO-d 6 ):(some signals are splitted due to presence of rotamers) δ (ppm) 7.92-7.82 (m, 2H, CH aromatic Fmoc group), 7.70-7.59 (m, 4H CH aromatic tosyl group + CH aromatic Fmoc group), 7.45- 7.18 (m, 6H CH aromatic Fmoc group + CH aromatic tosyl group), 4.33-4.00 (m, 3H CH 2 CH Fmoc), 3.31 (bs, 1H, C(2)-Hα), 3.14-2.87 (m, 6H, CH 2 arginine side chain + Glyψ CH 2 CH 2 ), 2.30 (s, 3H, CH 3 tosyl group), 1.66-1.38 (m, 13H, CH 2 arginine side chain + CH 3 Boc group). 13 C-NMR (75 MHz, DMSO-d 6 ,): δ(ppm) 175.0, 156.7, 155.9, 155.5, 143.8, 141.7, 140.8, 140.5, 128.8, 127.5, 127.1, 126.9, 125.4, 125.0, 119.9, 77.3, 66.4, 60.8, 48.3, 46.6, 45.2, 29.9, 28.1, 26.6, 20.7. ESI-MS (CH 3 OH, positive ions): calculated m/z: 694.81 (MH + ), 716.81 (MNa + ), 732.9 (MK + )found: 694.5, 716.4, 732.4. N α -Boc-[L-Argψ-(N ω -Tosyl)]-Gly methyl ester. N α -Boc-L-Arg-N ω -Tosyl-aldehyde (686.7 mg, 1.66 mmol) and Gly-OMe•HCl (250.8 mg, 2.00 mmol) were dissolved in MeOH (20 ml). The reaction mixture was cooled to 0° C with an ice bath and NaBH 3 CN (132.1 mg, 2.00 mmol), and acetic acid (144 µl, 2.00 mmol) were added to the stirred solution. The reaction 68
Arginine-PNAs was allowed to stir for 30 minutes at 0°C, then at room temperature for 4 hours. The solvent was evaporated and the residue was redissolved in EtOAc, and washed with saturated NaHCO 3 (3 times) and KHSO 4 (3 times). The organic layer was dried over Na 2 SO4, filtered and evaporated to afford an oil. The oil was purified via column flash chromatography (from EtOAc to AcOEt/MeOH 9:1) to afford a colorless foam. Yeld: 50%. 1 H NMR (300 MHz, CDCl 3 ): δ(ppm) 7.75 (d, 2H, J = 8.2 Hz, CH aromatic tosyl group), 7.22 (d, 2H, J = 8.2 Hz, CH aromatic tosyl group), 6.45 (bs, 3H, N–H), 5.00 (d, 1H, J = 8,4 Hz, NH-Boc), 3.72 (s, 3H, CH 3 methyl ester), 3.70-3.55 (m, 1H, C(5)Hα), 3.44 (d, 1H, J = 17,5 Hz, Gly CH 2 ), 3.35 (d, 1H, J = 17,5 Hz, C(2)H 2 ), 3.18 (bs, 2H, CH 2 NH side chain), 2.70-2.50 (m, 2H, Argψ CH 2 pseudopeptide moiety), 2.38 (s, 3H, CH 3 tosyl group), 1.78 (bs, 1H, NH amine), 1.61-1.43 (m, 4H, CH 2 CH 2 side chain),1.41 (s, 9H, CH 3 Boc group). 13 C NMR (75.4 MHz, CDCl 3 ): δ(ppm) = 172.8, 156.8, 156.2, 141.8, 140.6, 129.1, 125.7, 79.0, 53.5, 52.9, 51.6, 50.3, 40.7, 30.1, 28.2, 25.6, 21.2. ESI-MS(CH 3 OH, positive ions): calculated m/z 486.6 (MH + ), found 486.4. N α -Boc-[L-Argψ-(N ω -Tosyl)]-Gly[N α -(Z)carboxymethylcytosine] methyl ester. N4- benzoxycarbonyl-N1-carboxymethylcytosine (CMC(Z)) (502.9 mg, 1.65 mmol) was dissolved in DMF (10 ml) at 0° C, together with DHBtOH (268.8 mg, 1.65 mmol) and DIPEA (423 µl, 2.56 mmol). EDC•HCl (314.4 mg, 1.64 mmol) was then added, and the solution was stirred for 10 minutes at 0° C, then for 20 minutes at room temperature; N α -Boc-[L-Argψ- (N ω -Tosyl)]-Glymethyl ester (408.2 mg, 0.84 mmol) was then added to the mixture, and the solution was stirred overnight. After completion of the reaction the DMF was evaporated under vacuum. The residue was redissolved in AcOEt and washed with saturated KHSO 4 (3 times), and saturated NaHCO 3 (3 times). The organic layer was dried over Na 2 SO 4 and filtered; the solvent was removed and the residue was purified via flash chromatography (AcOEt/MeOH = 95 : 5) to afford the product as a pale yellow foam. Yeld 95%. 1 H NMR (300 MHz, CDCl 3 ): major rotamer δ(ppm) 10.81 (bs, 1H, NH Cytosine), 7.69 (d, 2H, J = 8.1 Hz, CH aromatic tosyl group), 7.55 (bs, 1H, C(6)H Cytosine), 7.35-7.10 (m, 8H, C(5)H Cytosine, CH aromatic tosyl and benzyl group), 6.55 (bs, 2H, NH), 5.56 (bs, 1H, NH-Boc), 5.16 (s, 2H, CH 2 benzyl group), 4.90-4.45 (m, 2H, CO-CH 2 -Cytosine), 4.40-3.85 (m, 2H, C(2)H 2 ), 4.00-3.70 (m, 2H, Argψ CH 2 ), 3.59 (s, 3H, CH 3 methyl ester), 3.41 (bs, 1H, C(5)H), 3.17 (bs, 2H, CH 2 NH Arg side chain), 2.32 (s, 3H, CH 3 tosyl group), 1.80-1.30 (m, 13H, CH 3 Boc group and CH 2 side chain). 13 C NMR (75.4 MHz, CDCl 3 ): major rotamer δ(ppm) 169.5, 167.4, 163.3, 156.9, 156.2, 156.0, 152.5, 150.2, 141.8, 140.9, 135.0, 129.1, 128.6, 128.3, 128.2, 125.9, 95.6, 79.7, 77.2, 67.7, 52.8, 52.2, 50.9, 49.2, 48.9, 40.2, 28.8, 28.3, 25.6, 21.4. 69
- Page 1 and 2:
Università degli studi di Parma Do
- Page 3 and 4:
2.4.4 Fluorescence measurements ...
- Page 5:
Chapter 6 The double nature of Pept
- Page 8 and 9:
Preface In Chapter 2 a particular t
- Page 11 and 12:
Chapter 1 PNAs: From birth to adult
- Page 13 and 14:
PNAs: from birth to adulthood one,
- Page 15 and 16:
PNAs: from birth to adulthood betwe
- Page 17 and 18:
PNAs: from birth to adulthood explo
- Page 19 and 20:
PNAs: from birth to adulthood well,
- Page 21 and 22:
PNAs: from birth to adulthood + Res
- Page 23 and 24: PNAs: from birth to adulthood repet
- Page 25 and 26: PNAs: from birth to adulthood 1.6 M
- Page 27 and 28: PNAs: from birth to adulthood amino
- Page 29 and 30: PNAs: from birth to adulthood Cycli
- Page 31 and 32: PNAs: from birth to adulthood DNA a
- Page 33 and 34: PNAs: from birth to adulthood 1.7 C
- Page 35 and 36: PNAs: from birth to adulthood Submo
- Page 37 and 38: PNAs: from birth to adulthood beaco
- Page 39 and 40: PNAs: from birth to adulthood DNA s
- Page 41 and 42: PNAs: from birth to adulthood this
- Page 43 and 44: PNAs: from birth to adulthood 42 C.
- Page 45 and 46: Chapter 2 Label-free detection of S
- Page 47 and 48: PNA Molecular Beacons Figure 2-1: S
- Page 49 and 50: PNA Molecular Beacons DNA is added,
- Page 51 and 52: PNA Molecular Beacons the affinitie
- Page 53 and 54: PNA Molecular Beacons In particular
- Page 55 and 56: PNA Molecular Beacons The sample th
- Page 57 and 58: PNA Molecular Beacons pipetting to
- Page 59 and 60: PNA Molecular Beacons The mastermix
- Page 61 and 62: Chapter 3 A new class of Chiral PNA
- Page 63 and 64: Arginine-PNAs monomers in the middl
- Page 65 and 66: Arginine-PNAs The synthesis of the
- Page 67 and 68: Arginine-PNAs yield in this reactio
- Page 69 and 70: Arginine-PNAs (increased electrosta
- Page 71 and 72: Arginine-PNAs chain + Boc methyl gr
- Page 73: Arginine-PNAs foam. Yield: 30%. 1 H
- Page 77 and 78: Arginine-PNAs PNAs was carried out
- Page 79 and 80: Chapter 4 Chiral PNA application on
- Page 81 and 82: Arg-PNA Microarrays a surface. Alth
- Page 83 and 84: Arg-PNA Microarrays 4.2 Results and
- Page 85 and 86: Arg-PNA Microarrays Figure 4-2: HPL
- Page 87 and 88: Arg-PNA Microarrays PNA-microarray
- Page 89 and 90: Arg-PNA Microarrays Table 4-2. Geno
- Page 91 and 92: Arg-PNA Microarrays complex mixture
- Page 93 and 94: Arg-PNA Microarrays hybridisation e
- Page 95: Arg-PNA Microarrays 30 T. Tedeschi,
- Page 98 and 99: Chapter 5 5.1 Introduction The incr
- Page 100 and 101: Chapter 5 be printed, in order to m
- Page 102 and 103: Chapter 5 Table 5-1. PNA sequences
- Page 104 and 105: Chapter 5 printing the PNA on a gla
- Page 106 and 107: Chapter 5 22.4°C 24.0°C 25.5°C 2
- Page 108 and 109: Chapter 5 PNA 3 PNA 5 PNA 6 Slide 1
- Page 110 and 111: Chapter 5 times. The substrates wer
- Page 112 and 113: Chapter 5 chemicals were used as re
- Page 114 and 115: Chapter 5 5.4.6 Microcontact Printi
- Page 116 and 117: Chapter 5 5.5 References 1 A. L. Be
- Page 118 and 119: Chapter 6 6.1 Introduction The use
- Page 120 and 121: Chapter 6 Among all the peptides us
- Page 122 and 123: Chapter 6 Figure 6-2: A standard PN
- Page 124 and 125:
Chapter 6 peptide 1 and the PNA tri
- Page 126 and 127:
Chapter 6 6.2.2 Uptake experiments
- Page 128 and 129:
Chapter 6 (HBTU), N-[(dimethylamino
- Page 130 and 131:
Chapter 6 1.41 (s, 9H, Boc methyl g
- Page 132 and 133:
Chapter 6 Arg + CHα Lys), 4.0-4.6
- Page 134 and 135:
Chapter 6 12 B. P. Gangamani, V. A.
- Page 136 and 137:
Contributions Publications includin